Characterizing neurofibromin 1-altered breast cancer through genomic, functional, and clinical analyses.

Detalles Bibliográficos
Publicado en:Virchows Archiv: European Journal of Pathology Vol. 489; no. 2; pp. 409 - 426
Autores principales: Mao, Xueyan, Ma, Kang, Wang, Yunjie, Long, Cheng, Tan, Xuejing, Chen, Xi, Chen, Bo
Formato: Journal Article
Publicado: Springer Nature Aug2026
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=196215241&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 196215241
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        09456317
        O1Z
      jtl: Virchows Archiv: European Journal of Pathology
      issn: 09456317
      maglogo: N
    pubinfo:
      dt: Aug2026
      vid: 489
      iid: 2
      pid: 237
      pub: Springer Nature
      place: New York, New York
    artinfo:
      ui:
        196215241
        187294830
        10.1007/s00428-025-04218-y
        196215241
      ppf: 409
      ppct: 17
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: Characterizing neurofibromin 1-altered breast cancer through genomic, functional, and clinical analyses.
      aug:
        au:
          Mao, Xueyan
          Ma, Kang
          Wang, Yunjie
          Long, Cheng
          Tan, Xuejing
          Chen, Xi
          Chen, Bo
        affil: https://ror.org/03mqfn238 Institute of Clinical Anatomy & Reproductive Medicine, Hengyang Medical School, University of South China, 421000, Hengyang, Hunan, China
      sug:
      pubtype: Academic Journal
      doctype: Journal Article
      ougenre: Article
      ab:
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N